Gainers
- Emmaus Life Sciences, Inc. EMMA jumped 33.1% to $5.65.
- SigmaTron International, Inc. SGMA shares climbed 22.6% to $3.2754 after the company reported Q4 results.
- Huitao Technology Co. Ltd. HHT gained 21.6% to $4.4271.
- Nuvectra Corporation NVTR rose 19.9% to $2.47.
- Manhattan Associates, Inc. MANH gained 18.7% to $86.43 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 EPS and sales guidance above analyst estimates.
- Teradyne, Inc. TER shares climbed 18.4% to $56.95 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 EPS and sales guidance on the high end of analyst estimates.
- Neuralstem, Inc. CUR gained 17% to $5.32.
- Snap Inc. SNAP shares rose 15% to $17.06 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance above analyst estimates and an increase in daily active users from Q2 last year.
- Genomic Health, Inc. GHDX gained 13.8% to $64.58.
- Constellium SE CSTM shares climbed 13.2% to $11.81.
- Acasti Pharma Inc. . ACST rose 12.4% to $2.2815.
- Integra LifeSciences Holdings Corporation IART climbed 12% to $62.11 following Q2 results.
- Tenet Healthcare Corporation THC climbed 11.6% to $19.61.
- Navient Corporation NAVI rose 11.2% to $15.23 after the company reported better-than-expected Q2 EPS results.
- Lithia Motors, Inc. LAD climbed 11.2% to $131.49 following strong Q2 results.
- M/I Homes, Inc. MHO rose 10.4% to $31.92 following upbeat Q2 earnings.
- Jounce Therapeutics Inc JNCE shares gained 10% to $4.50 after the company announced an update on its strategic collaboration with Celgene.
- Discover Financial Services DFS rose 8.7% to $91.80 after the company reported better-than-expected Q2 EPS and sales results.
- Sprint Corporation S rose 8.4% to $7.68. Dish agreed to a $5 billion deal for wireless assets in deal with T-Mobile and Sprint, Bloomberg reported.
- Edwards Lifesciences Corporation EW shares rose 8.2% to $211.57 after the company reported better-than-expected Q2 EPS and sales guidance. The company also raised FY19 EPS and sales guidance.
- Xenetic Biosciences, Inc. XBIO shares rose 7.6% to $2.97 after dropping 17.86% on Tuesday.
- Texas Instruments Incorporated TXN rose 7.5% to $129.03 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance in-line with analyst estimates.
- Chipotle Mexican Grill, Inc. CMG rose 5.4% to $779.41 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 comps.
Check out these big penny stock gainers and losers
Losers
- Healthcare Services Group, Inc. HCSG shares dipped 22.2% to $23.41 after reporting downbeat Q2 results.
- CannTrust Holdings Inc. CTST fell 21.2% to $2.0650 after declining 4.03% on Tuesday.
- iRobot Corporation IRBT dropped 18.2% to $73.29 after the company reported Q2 EPS and sales results down from last year. The company also issued FY19 sales guidance below analyst estimates.
- Tupperware Brands Corporation TUP dropped 18.2% to $14.58 after the company reported downbeat Q2 results and lowered its guidance.
- Therapix Biosciences Ltd. TRPX fell 16.2% to $2.85 after climbing 47.83% on Tuesday.
- LSC Communications, Inc. LKSD dropped 16.2% to $1.92. Wells Fargo downgraded LSC Communications from Market Perform to Underperform.
- Eagle Bulk Shipping Inc. EGLE fell 15.6% to $4.6350 after the company announced a $100 million offering of convertible senior notes due 2024.
- Chiasma, Inc. CHMA dropped 15.2% to $6.67.
- Calix, Inc. CALX declined 14.2% to $6.26 following Q2 results.
- Golden Bull Limited DNJR dropped 11.4% to $1.87.
- Fang Holdings Limited SFUN shares fell 10.8% to $2.31.
- Rollins, Inc. ROL dropped 9.9% to $34.36 after the company reported worse-than-expected Q2 sales.
- MarketAxess Holdings Inc. MKTX fell 9.3% to $333.50 following downbeat Q2 earnings.
- Dynavax Technologies Corporation DVAX dropped 7.5% to $2.98.
- Seattle Genetics, Inc. SGEN shares fell 5.6% to $71.67. Seattle Genetics priced 7.1 million share public offering of common stock at $70 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralApplication SoftwareInformation TechnologyMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in